More on SPTX

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (8.0 Score)

Upcoming Events

- Earnings (9/2/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

(NQ:SPTX)
Delayed: 21.58 +1.07 (5.22%)
Prev. Close $20.51  
Open$20.57 
52 Wk High$ 
52 Wk Low$ 
Day High$21.75 
Day Low$19.38 
P/E N/A  
EPS$ 
Volume76,159 

Friends, Peers and Foes (?): PRTC (more...)

Jun 24, 2026 06:05 AM Form 4 Seaport Therapeutics, For: Jun 22 Filed by: HOMBACH ROBERT J.
Jun 9, 2026 03:34 AM Stifel Reiterates Buy Rating on Seaport Therapeutics (SPTX)
Jun 9, 2026 02:00 AM Seaport Therapeutics reports positive phase 1 data for GlyphAgo anxiety drug
Jun 9, 2026 02:00 AM PureTech Founded Entity Seaport Therapeutics Reports Positive Multiple-Ascending Dose Data from Phase 1 Proof-of-Concept Trial of GlyphAgo™ in Healthy Volunteers
Jun 8, 2026 07:16 AM Form 10-Q Seaport Therapeutics, For: Mar 31
Jun 8, 2026 07:12 AM Form 8-K Seaport Therapeutics, For: Jun 08
Jun 8, 2026 07:05 AM Seaport Therapeutics Reports First Quarter 2026 Financial Results and Highlights Recent Corporate and Clinical Progress
Jun 8, 2026 07:00 AM Seaport Therapeutics reports positive phase 1 data for anxiety drug candidate
Jun 8, 2026 07:00 AM Seaport Therapeutics Reports Positive Multiple-Ascending Dose Data from Phase 1 Proof-of-Concept Trial of GlyphAgo™ in Healthy Volunteers
Jun 1, 2026 07:00 AM Seaport Therapeutics to Participate in Two Upcoming Investor Conferences
View All Articles

Entities mentioned with SPTX

View All Entities